Here's what the data shows: 10.6% average weight loss in just 24 weeks Twice the efficacy of currently approved obesity drugs Oral tablets - no weekly injections required Triple mechanism targeting dopamine, serotonin AND norepinephrine The most impressive part
It is widely recognised that metformin improves glycaemic control with a good safety profile, weight neutrality or weight loss, lack of associated hypoglycaemia, reduced cardiovascular mortality and low cost [3]
Dynamics of gut-brain communication underlying hunger
Supplementation with Pycnogenol(R) improves signs and symptoms of menopausal transition
He is concerned that people who view exercise only as a weight-loss strategy might be less inclined to be physically active after taking one of the new GLP-1 drugs by thinking, Why exercise since I can lose weight with a drug? That would be a big mistake.
A 50% jump in warning letters signals that CDERs compliance teams are more active and more aggressive than in prior years